March 30, 2026 by Medigroup
Healthcare supply costs do not wait for convenient timing. Tariffs shift overnight. Drug shortages stretch for years. For most physician offices, surgery centers, and specialty clinics, the procurement process runs on autopilot: the same vendors, the same contracts, renewing quietly while margins shrink.
A “Group Purchasing Organization,” or GPO, exists to change that dynamic. This guide explains exactly how GPOs work, what they save, where the criticism comes from, and how to find a partner that fits your practice. No fees, no complexity, and no disruption to what already works.
A group purchasing organization is a supply chain intermediary that pools the purchasing volume of many healthcare providers to negotiate lower prices from manufacturers, distributors, and service vendors. The GPO does not buy the products itself. It negotiates the contracts. Member facilities then use those contracts when they place their own orders, at pre-negotiated rates.
The model dates to 1910, when the first pooled purchasing program emerged among member provider institutions. Today, most GPO membership is free to the provider. GPOs fund their operations through administrative fees paid by the vendors and manufacturers whose products appear on the contract portfolio. This structure means a physician practice or surgery center can access enterprise-level pricing without a procurement department, a legal team, or a membership fee.
The process is more straightforward than most practice managers expect:
1. Join a GPO at no cost, with no obligation to use every contract available.
2. Access the contract portfolio for vetted manufacturers and service vendors, negotiated using collective volume across all member facilities.
3. Place orders through your existing distributors at GPO-negotiated rates.
4. Vendors pay the GPO an administrative fee, typically a small percentage of purchases made under the contract.
5. Keep your current vendor relationships and your purchasing autonomy. You gain access to better pricing without switching anything.
This flexibility matters. A GPO that forces supplier switches or complete procurement overhauls creates friction. A good GPO lets practices access contracts where the savings are clearest, at their own pace, with no penalties for partial adoption.
The savings figures cited for GPOs vary depending on who conducts the research and how they measure results. Three data points frame the current picture clearly:
These figures differ because they measure different things. Industry-funded reports capture broad system-level projections. Independent econometric studies measure the marginal effect of GPO scale at the facility level. Both tell the same directional story: GPO membership reduces supply costs. The magnitude depends on the size of the practice, the categories purchased, and the quality of the contract portfolio accessed.
For physician offices, surgery centers, and specialty clinics, the per-contract savings on medical supplies, pharmaceuticals, laboratory supplies, and office products can represent the difference between a margin and a loss.
Cost reduction gets the headline, but it is not the only reason non-acute care facilities join GPOs. The benefits extend across several areas that matter to day-to-day operations:
Not every GPO fits every facility type. When a practice evaluates GPO options, these criteria separate a strong partner from a poor fit:
The tariff environment of 2025 created new pressure on healthcare supply chains. A KPMG survey of healthcare executives found that China represents the top import source for U.S. healthcare organizations, accounting for an average of 29% of imports, with 43% of healthcare executives reporting a 16 to 25% cost increase on products sourced from China.
Physician offices, surgery centers, and specialty clinics feel this pressure acutely. Unlike large integrated systems with dedicated procurement teams, most non-acute care practices lack the internal capacity to monitor tariff changes, renegotiate supplier contracts, or identify alternative sourcing channels in real time.
GPOs offer one structural buffer against this pressure. GPO contracts with tariff protection clauses, multi-source supplier options, and diversified geographic sourcing reduce the exposure a single practice faces when tariff changes hit a specific product category. GPO membership shifts negotiating leverage and supply diversification to a level that a single physician practice or surgery center cannot achieve alone.
Artificial intelligence reshapes the GPO model from reactive contract management to predictive supply chain management. The capabilities now entering production at leading GPOs include:
A 2024 survey found that 80% of healthcare supply chain leaders expect challenges to worsen or stay the same in 2025, and supply shortages cost a medium-size practice network an average of $3.5 million per year. These conditions make predictive, AI-assisted GPO services a practical necessity, not a premium add-on.
This table shows what changes and what stays the same when a physician office, surgery center, or specialty clinic joins a GPO:
| What Your Practice Needs | With a GPO Partner | Without a GPO |
|---|---|---|
| Pre-negotiated supply contracts | Available at no cost, from day one | Requires internal negotiation capacity |
| Practice-level pricing on supplies | Yes, through aggregated volume purchasing | Unlikely at single-practice scale |
| Pharmaceutical and lab supply access | Covered across comprehensive portfolios | Dependent on distributor pricing only |
| Capital equipment discounts | Exclusive member pricing available | Standard list pricing applies |
| Tariff protection clauses | Built into quality GPO contracts | Your responsibility to negotiate alone |
| Drug shortage alternatives | Pre-qualified backup suppliers on standby | Manual search at time of crisis |
| Operational spend coverage | Waste, office, IT, and services included | Separate vendor negotiations required |
| Employee benefits programs | Available through member programs | Not available |
| Cost to join | Free | Not applicable; procurement costs more |
| Flexibility to keep current distributor | Yes, distributor-friendly model | Yes, but without contract leverage |
Most large GPOs focus on hospital systems. Physician practices, surgery centers, specialty clinics, and urgent care centers operate at a different scale with different needs. MediGroup was built specifically for this market.
Since 1999, MediGroup has grown into the nation’s largest non-acute GPO in the US, with over 250,000 healthcare employees depending on them to negotiate the best prices.
MediGroup’s contract portfolio covers clinical and operational spend across:
In 2002, MediGroup developed the first GPO distributor-friendly model, a structure that keeps existing distributor relationships intact while layering in contract savings. This model has remained central to how MediGroup serves its members, and it addresses the most common hesitation practices have about GPO membership: the concern about disruption.
For facilities evaluating GPO partners, MediGroup represents a practical starting point: no fee, no mandated supplier switches, a focused portfolio built around non-acute care realities, and nearly three decades of contracting expertise in this specific market.
A GPO negotiates contracts for a broad range of healthcare supplies, pharmaceuticals, and services on behalf of provider facilities. A pharmacy benefit manager, or PBM, manages prescription drug benefits on behalf of insurers or employers, primarily focused on the retail pharmacy channel and member drug coverage, not facility-level supply procurement. The two serve different functions in the healthcare supply chain.
Yes. GPO membership does not require exclusive purchasing through GPO contracts. Practices retain full purchasing autonomy and can use GPO contracts where the pricing is advantageous, while continuing to purchase other products through their normal channels. Quality GPOs support this flexibility rather than restrict it.
They do not affect member facilities directly. Administrative fees are paid by vendors to the GPO, not by member facilities. The 1986 congressional safe harbor requires disclosure of fees above 3% to member facilities. For members, the relevant question is whether the GPO’s fee structure creates incentives to favor certain vendors over better-value alternatives.
The evidence on this is contested. The 2024 FTC and HHS joint investigation sought public comment on whether GPO contracting practices, particularly exclusive and bundled contracts, reduce manufacturer incentives to maintain production of low-margin generic drugs. No regulatory finding has concluded that GPOs cause shortages. The investigation reflects legitimate concern about market structure, not a determination of cause.
Most facilities use two to four GPOs simultaneously. Different GPOs offer stronger contracts in different categories. There is no cost to membership, so overlapping memberships are common and practical. The key is to ensure the primary GPO covers the categories most relevant to a practice’s clinical and operational spend.
The GPO model is not static. Consolidation continues at the top of the market, with major acquisitions and divestitures reshaping the landscape. Regulators pay closer attention to contracting practices. AI transforms what GPOs can deliver beyond contract negotiation.
The physician offices, surgery centers, and specialty clinics that benefit most from this evolution treat GPO membership as an active procurement tool, not a passive contract library. The question is not whether to use a GPO. The question is which GPO fits the scale, specialty mix, and operational priorities of your practice, and whether your current purchasing structure already captures the savings that exist within your contracts.
For non-acute care facilities, that question has a clear starting point.
Healthcare Supply Chain Association (supplychainassociation.org); ScienceDirect, Journal of Public Economics, “The Value of Group Purchasing” (2025); FTC/HHS Joint Request for Information on Generic Drug Shortages (February 2024); GAO Drug Shortages Report GAO-25-107110 (April 2025); KPMG, “Impact of Tariffs on Healthcare” (2025); MediGroup, member data and service descriptions.